A detailed history of Vivaldi Capital Management LP transactions in Eli Lilly & CO stock. As of the latest transaction made, Vivaldi Capital Management LP holds 2,419 shares of LLY stock, worth $2.21 Million. This represents 0.55% of its overall portfolio holdings.

Number of Shares
2,419
Previous 2,605 7.14%
Holding current value
$2.21 Million
Previous $1.52 Million 23.91%
% of portfolio
0.55%
Previous 0.45%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$592.2 - $792.28 $110,149 - $147,364
-186 Reduced 7.14%
2,419 $1.88 Million
Q4 2023

Feb 14, 2024

BUY
$525.19 - $619.13 $167,535 - $197,502
319 Added 13.95%
2,605 $1.52 Million
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $31,733 - $43,748
73 Added 3.3%
2,286 $1.23 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $4,559 - $6,096
13 Added 0.59%
2,213 $1.04 Million
Q1 2023

May 12, 2023

SELL
$310.63 - $364.82 $6,523 - $7,661
-21 Reduced 0.95%
2,200 $755,000
Q4 2022

Feb 14, 2023

BUY
$321.55 - $374.67 $40,193 - $46,833
125 Added 5.96%
2,221 $812,000
Q3 2022

Nov 14, 2022

BUY
$296.48 - $337.87 $6,522 - $7,433
22 Added 1.06%
2,096 $685,000
Q2 2022

Aug 15, 2022

BUY
$278.73 - $327.27 $6,132 - $7,199
22 Added 1.07%
2,074 $672,000
Q1 2022

May 16, 2022

BUY
$234.69 - $291.66 $1,642 - $2,041
7 Added 0.34%
2,052 $598,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $1,349 - $1,674
6 Added 0.29%
2,045 $565,000
Q2 2021

Aug 16, 2021

SELL
$180.55 - $233.54 $6,499 - $8,407
-36 Reduced 1.73%
2,039 $539,000
Q1 2021

May 17, 2021

SELL
$164.32 - $212.72 $8,873 - $11,486
-54 Reduced 2.54%
2,075 $407,000
Q4 2020

Feb 16, 2021

BUY
$130.46 - $172.63 $7,436 - $9,839
57 Added 2.75%
2,129 $359,000
Q3 2020

Nov 16, 2020

SELL
$146.22 - $169.13 $78,812 - $91,161
-539 Reduced 20.64%
2,072 $295,000
Q2 2020

Aug 13, 2020

BUY
$136.42 - $164.18 $356,192 - $428,673
2,611 New
2,611 $398,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $869B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Vivaldi Capital Management LP Portfolio

Follow Vivaldi Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Vivaldi Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Vivaldi Capital Management LP with notifications on news.